Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ir J Med Sci. 2010 Sep;179(3):431-3. doi: 10.1007/s11845-009-0324-6. Epub 2009 Apr 8.

Recombinant activated factor VII to control life-threatening haemorrhagic radiation cystitis.

Author information

  • 1Department of Urology, University College Hospital Galway, Galway, Ireland. steconnolly@rcsi.ie

Abstract

INTRODUCTION:

The use of recombinant activated factor VII has been described for many clinical scenarios, but the value of this therapeutic agent for life-threatening haemorrhagic cystitis remains novel.

METHOD:

We describe a case of persistent life-threatening haemorrhagic radiation cystitis, and discuss current knowledge of this therapy including potential complications.

RESULT:

Control of haemorrhage was successfully achieved only after use of this agent.

CONCLUSION:

This therapy deserves mention in any future management algorithm devised for this condition.

PMID:
19352582
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk